Breast cancer progression and outcome are determined not only by characteristics of the tumor epithelial cells, but also by the overall arrangement and activity of the tumor stroma. Our previous work has demonstrated that gene expression signatures in human tumor stroma can predict outcome of breast cancer patients independently of established clinical parameters and molecular subtypes. The goal of this project is to use a systems approach to define the crifical pathways mediating communication between the tumor epithelium and stromal compartments in the poor outcome-associated triple-negative (TN) and HER2-positive (HER2+) human breast cancer molecular subtypes. We will extend our previous work in an attempt to better define stromal subtypes using both mRNA and miRNA expression patterns. This project has three major aims:
Aim 1. To develop coordinate stromal-epithelial expression signatures for TN and HER2+ breast cancer. Stroma and tumor epithelium compartments will be isolated by laser capture microdissection from a set of previously banked tumor samples that are linked to diagnostic, treatment and outcome information. Gene expression profiles will be generated for each, and the resulting data will be analyzed to further characterize specific signatures as well as to compare the results with those obtained from mouse models in projects 1 and 2.
Aim 2. To identify stromal-epithelial gene interaction networks. Using a de novo bioinformatics methodology termed STR-EPI, genes and pathways showing coordinated behavior and potenfially modulating crosstalk between the two compartments will be identified, with a focus on secreted and cell-surface proteins that may directly mediate communication. These results will be validated in available larger sample sets and directly examined experimentally with Projects 2 and 3, and their links to outcome and response to therapy will be investigated.
Aim 3. To identify and integrate stromal-epithelial and serum-derived miRNA signatures. Profiles will be generated from miRNA isolated in parallel from the samples described above, as well as from matched serum samples. These will be analyzed in tandem with mRNA data in order to develop robust and highly accurate clinically accessible biomarkers for stroma/epithelial features and microenvironment-based classification.

Public Health Relevance

The identification of pathways governing interactions between breast cancer cells and the surrounding stroma will permit the development of novel prognostic markers and potential therapeutic targets. miRNA based tests suitable for use in standard clinical material, includingserum, will allow improved patient stratification, staging and therapeutic decision-making, leading to more personalized treatment.

Agency
National Institute of Health (NIH)
Type
Research Program Projects (P01)
Project #
5P01CA097189-08
Application #
8678859
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
City
Columbus
State
OH
Country
United States
Zip Code
43210
Mathsyaraja, H; Thies, K; Taffany, D A et al. (2015) CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth. Oncogene 34:3651-61
Meisen, Walter Hans; Dubin, Samuel; Sizemore, Steven T et al. (2015) Changes in BAI1 and nestin expression are prognostic indicators for survival and metastases in breast cancer and provide opportunities for dual targeted therapies. Mol Cancer Ther 14:307-14
Kabbout, Mohamed; Dakhlallah, Duaa; Sharma, Sudarshana et al. (2014) MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation. PLoS One 9:e100693
Wallace, Julie A; Li, Fu; Balakrishnan, Subhasree et al. (2013) Ets2 in tumor fibroblasts promotes angiogenesis in breast cancer. PLoS One 8:e71533
Bronisz, A; Godlewski, J; Wallace, J A et al. (2012) Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol 14:159-67
Ouseph, Madhu M; Li, Jing; Chen, Hui-Zi et al. (2012) Atypical E2F repressors and activators coordinate placental development. Dev Cell 22:849-62
Thudi, Nanda K; Martin, Chelsea K; Murahari, Sridhar et al. (2011) Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases. Prostate 71:615-25
Wenzel, Pamela L; Chong, Jean-Leon; Saenz-Robles, M Teresa et al. (2011) Cell proliferation in the absence of E2F1-3. Dev Biol 351:35-45
Wallace, Julie A; Li, Fu; Leone, Gustavo et al. (2011) Pten in the breast tumor microenvironment: modeling tumor-stroma coevolution. Cancer Res 71:1203-7
Trikha, Prashant; Sharma, Nidhi; Opavsky, Rene et al. (2011) E2f1-3 are critical for myeloid development. J Biol Chem 286:4783-95

Showing the most recent 10 out of 39 publications